Isatuximab in the Treatment of Multiple Myeloma: A Review and Comparison with Daratumumab
TECHNOLOGY IN CANCER RESEARCH & TREATMENT(2022)
Key words
isatuximab,monoclonal antibody,anti-CD38 antibody,relapsed,refractory,multiple myeloma,daratumumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined